
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216
Verena Gress, Mathieu Roussy, Luc Boulianne, et al.
Blood Advances (2023) Vol. 8, Iss. 1, pp. 112-129
Open Access | Times Cited: 13
Verena Gress, Mathieu Roussy, Luc Boulianne, et al.
Blood Advances (2023) Vol. 8, Iss. 1, pp. 112-129
Open Access | Times Cited: 13
Showing 13 citing articles:
Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?
Riccardo Masetti, Francesco Baccelli, Davide Leardini, et al.
Blood Advances (2024) Vol. 8, Iss. 13, pp. 3583-3595
Open Access | Times Cited: 4
Riccardo Masetti, Francesco Baccelli, Davide Leardini, et al.
Blood Advances (2024) Vol. 8, Iss. 13, pp. 3583-3595
Open Access | Times Cited: 4
Advancements in programmed cell death research in antitumor therapy: a comprehensive overview
Shuxin Wei, Chuangye Han, Shutian Mo, et al.
APOPTOSIS (2024)
Closed Access | Times Cited: 4
Shuxin Wei, Chuangye Han, Shutian Mo, et al.
APOPTOSIS (2024)
Closed Access | Times Cited: 4
Protein degraders - from thalidomide to new PROTACs
Takumi Ito
The Journal of Biochemistry (2023) Vol. 175, Iss. 5, pp. 507-519
Open Access | Times Cited: 10
Takumi Ito
The Journal of Biochemistry (2023) Vol. 175, Iss. 5, pp. 507-519
Open Access | Times Cited: 10
Novel classification system and high-risk categories of pediatric acute myeloid leukemia
Masayuki Umeda, Yen‐Chun Liu, Seth E. Karol, et al.
Haematologica (2025)
Open Access
Masayuki Umeda, Yen‐Chun Liu, Seth E. Karol, et al.
Haematologica (2025)
Open Access
Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies
Amanda E. Marinoff, Kathryn Aaronson, Anurag K. Agrawal, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 6
Open Access | Times Cited: 8
Amanda E. Marinoff, Kathryn Aaronson, Anurag K. Agrawal, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 6
Open Access | Times Cited: 8
CBFA2T3 Is PPARA Sensitive and Attenuates Fasting-Induced Lipid Accumulation in Mouse Liver
Donghwan Kim, Sang Keun Ha, Frank J. Gonzalez
Cells (2024) Vol. 13, Iss. 10, pp. 831-831
Open Access | Times Cited: 2
Donghwan Kim, Sang Keun Ha, Frank J. Gonzalez
Cells (2024) Vol. 13, Iss. 10, pp. 831-831
Open Access | Times Cited: 2
Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndrome
Milica Miladinovic, Dirk Reinhardt, Henrik Hasle, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 9
Open Access | Times Cited: 2
Milica Miladinovic, Dirk Reinhardt, Henrik Hasle, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 9
Open Access | Times Cited: 2
Recent Updates in Venetoclax Combination Therapies in Pediatric Hematological Malignancies
Maria Leśniak, Justyna Lipniarska, Patrycja Majka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16708-16708
Open Access | Times Cited: 4
Maria Leśniak, Justyna Lipniarska, Patrycja Majka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16708-16708
Open Access | Times Cited: 4
Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment
Monika Chomczyk, Luca Gazzola, Shubhankar Dash, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Monika Chomczyk, Luca Gazzola, Shubhankar Dash, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Developmental interplay between transcriptional alterations and a targetable cytokine signaling dependency in pediatric ETO2::GLIS2 leukemia
Verónica Alonso-Pérez, Klaudia Galant, Fabien Boudia, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access
Verónica Alonso-Pérez, Klaudia Galant, Fabien Boudia, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access
CBFA2T3-GLIS2 mediates transcriptional regulation of developmental pathways through a gene regulatory network
Elizabeth A.R. Garfinkle, Pratima Nallagatla, Binay K. Sahoo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Elizabeth A.R. Garfinkle, Pratima Nallagatla, Binay K. Sahoo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines
Safia Safa-Tahar-Henni, Karen L. Martinez, Verena Gress, et al.
Leukemia (2024)
Open Access
Safia Safa-Tahar-Henni, Karen L. Martinez, Verena Gress, et al.
Leukemia (2024)
Open Access
G3BP1::CSF1R: a new and actionable gene fusion in acute megakaryoblastic leukemia
Xi Luo, Eric C. K. Cheng, Hoi–Yun Chan, et al.
Blood Advances (2024)
Open Access
Xi Luo, Eric C. K. Cheng, Hoi–Yun Chan, et al.
Blood Advances (2024)
Open Access